Reviva Pharmaceuticals Q4 EPS $(0.57) Misses $(0.10) Estimate

Reviva Pharmaceuticals (NASDAQ: RVPH) reported a Q4 loss of $(0.57) per share, missing the analyst consensus estimate of $(0.10) by 455.88%. This represents an 81.1% improvement compared to losses of $(3.00) per share in the same quarter last year.